Abbott Laboratories
NYSE: ABT
$116.96
-$0.78 (-0.7%)
Real Time Data Delayed 15 Min.
ABT Articles
Judging by moves among the most shorted stocks traded on the New York Stock Exchange, short sellers took a cautious approach late last month,
Published:
Last Updated:
These are stocks that make good sense for investors looking to add to their overall equity holdings. They are all trading well below their 52-week highs and should be attracting substantial...
Published:
Last Updated:
With the top pharmaceutical stocks trailing the market by a large margin, they are starting to look very attractive for long-term growth and income investors.
Published:
Last Updated:
Last week, following the election, the insiders were back with a vengeance, and the buyers were out in full force.
Published:
Last Updated:
With earnings for the third quarter wrapping up, executives and 10% owners that are insiders are once again free to trade shares, and volume is starting to pick up again.
Published:
Last Updated:
The relentless populist rhetoric has lowered the prices on some of the top pharmaceutical companies, and long-term growth and income investors have a chance to buy some great stocks on sale.
Published:
Last Updated:
These are 14 companies in the S&P 500 Index that have at least a 25 year history of dividend hikes and that seem likely to keep increasing their dividends in the coming years.
Published:
Last Updated:
With everything from analysts lowering estimates to the political cycle to a very hard to follow Federal Reserve, the ingredients are there for a witches brew of volatility.
Published:
Last Updated:
All these companies have faced issues. However, investors that bought and held shares over time did very well on a total return basis.
Published:
Last Updated:
St. Jude Medical has issued a press release aimed at responding to points in the Muddy Waters report, and a Credit Suisse research report has dispelled some of the concerns.
Published:
Last Updated:
Here are eight well-known stocks with either unusual or massive gains seen in their short interest as of the May 13, 2016, settlement date.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include Baidu, Enterprise Products Partners, Kinder Morgan, Kinross Gold, Marketo, Office Depot, Staples, Walt Disney,...
Published:
Last Updated:
Investors love when companies pay dividends. More specifically, they love companies that are raising their dividends year after year.
Published:
Last Updated:
Top analyst upgrades, downgrades and initiations seen Thursday morning include Abbott Labs, American Express, Apple, Citrix, ConocoPhillips, Kinder Morgan, Qualcomm, ServiceNow and Tesla Motors.
Published:
Last Updated:
With investors looking for safety and dividends for total return, the big pharmaceutical stocks are just the ticket, and these four are outstanding.
Published:
Last Updated: